However, as the cell line used in this study is BRAF wildtype it is still possible that CEACAM1 signaling affects IGFBP7 expression in certain subsets of patients (e.g. patients with BRAF wildtype melanoma). The gene discussed is IGFBP7; the disease is melanoma.